|
Re: Would Love your 2 cents....
The risk of ONJ (osteoneucrosis of the jaw) is higher with the IV biphosphanate (Zometa) then it is for the oral (Actinol, Fosomax). So to me, if the risk of bone cancer recurrance is not significant, and the benefits of switching to Zometa is not significant, then I would think it not worth the increased risk of ONJ with the Zometa.
__________________
*** MARYANNE *** aka HARRIECANARIE
1993: right side DCIS, lumpectomy, rads
1999: left side DCIS, lumpectomy, rads, tamoxifen
2006:
BRCA 2 positive
Stage I, invasive DCIS (6mm x 5mm)
Grade: intermediate
sentinal node biopsy: neg
HER2/neu amplified 4.7
ER+/PR+
TOPO II neg
Oncotype dx 20
Bilat mastectomy with DIEP flap reconstruction
oophorectomy
2007:
6 cycles TCH (taxotere, carboplatin, herceptin)
finished 1 yr herceptin 05/07
Arimidex, stopped after almost 1 yr
Femara
|